Interviews
Pioneers in Bioprocessing: Q&A with Biopharma Executive, Steven Lang, Ph.D.
Biotech and synthetic biology companies have much to do. Handling everything in-house—from strain design to process development—can stretch funding and resources thin.
.png)
Why Have Bioprocess Data Solutions Been Overlooked…Until Now?
Given the glaring challenge of managing bioprocess data, the question remains: Why have bioprocess data solutions been historically overlooked?
From Data Lakes to AI: An Interview with Invert’s Head of AI
Suhas Guruprasad, the Head of AI at Invert, dives into the evolution of artificial intelligence, distinguishing between the actual capabilities of AI and the often exaggerated hype surrounding it.
.png)
Pioneers in Bioprocessing: Q&A with Alexi Goranov of SCiFi Foods
Exciting news! Invert is launching a Q&A series, Pioneers in Bioprocessing, to chat with experts in bioprocessing and biotechnology to discuss their work, the potential of the bioeconomy at large, and the personal viewpoints of the individuals who make this work possible.
Bioprocess Tech Transfer: Navigating The Data Dilemma
The transfer of institutional data and knowledge is critical to the development of biotechnologies, bioproducts, and biotherapeutics.
A Guide to Build vs Buy: Biotech Software Edition
For biotech and synthetic biology companies, there’s always A LOT of work to do. As these companies quickly learn, trying to handle everything in-house–from strain design and high-throughput screening to process development and beyond–can spread funding and resources thinly.
